Usually, health policy makers face a trade-off between benefits and costs from healthcare markets regulation and deregulation. We argue that these markets and policy reforms should not be studied in isolation as the effects from regulation in one market spillover to other markets. In particular,...

Usually, health policy makers face a trade-off between benefits and costs from healthcare markets regulation and deregulation. We argue that these markets and policy reforms should not be studied in isolation as the effects from regulation in one market spillover to other markets. In particular,...